Golf ball deburring apparatus

Protect your idea by filing a Provisional or Utility Patent Application with the PowerPatent Patent Service. It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Nike, Inc. patent solves the following problem:

Many golf balls made of many layers. Many of these golf balls are produced using an injection molding technique. While many of the inner surface of a typical golf ball mold is smooth, various face kal created the product in common techniques to form.

Our analysis of this patent is as follows:

Nike, Inc.’s patent US 8469773 B2 deals with Golf ball deburring apparatus.
A framework for deburring a ball given. building includes an arm, a gear structure for changing the effective length of the arm, and a cam framework for the effective angular position of the arm. A finger with a sharp face retaliate arm. A ball placed on a rotating position held and the effective position for the sharp face contact and take at least a burr on the ball.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Automatic gain control with out of band blocking signal compensation

Be the First-to-File and Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Starkey Laboratories, Inc. patent solves the following problem:

As wireless devices become more common, the potential for signal interference from the many radio sources increases. If the gain of a receiver not properly adjust for the incoming signal strength of the desired signal, the receiver would be wrong sensitive or hyper sensitive. A more sensitive receiver is likely to be a poor recipient of a lower level desired signal. A more sensitive receiver is more susceptible to noise interference. Strong signal from improper sources also increase the chance of poor reception because of over loading the front end receiver increases the chance of false signal detection.

Our analysis of this patent is as follows:

Starkey Laboratories, Inc.’s patent US 8472573 B2 deals with Automatic gain control with out of band blocking signal compensation.
A picture of this subject include a way to receive an input signal. approach, in various embodiments, includes detecting a peak of the input signal and detecting an envelope of the input signal. In various embodiments, the peak envelope and used to identify out-of-band blocking signals and adjust gain control. method also includes comparing the peak of a first opening TP and comparing the envelope into a second door Te. By the way, if the peak above the entrance and the envelope is below a second threshold, then ignore the input signal. If the envelope is on the second door, the method involves applying automatic gain control to interpret the information encoded in the input signal.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Systems and methods for aneurysm treatment and vessel occlusion

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The Imds Corporation, , Neil Duggal patent solves the following problem:

The invention relates to endovascular treatment, and particularly, to systems and methods for aneurysm treatment and chosen vessel occlusion.

Our analysis of this patent is as follows:

Imds Corporation, , Neil Duggal’s patent US 8470013 B2 deals with Systems and methods for aneurysm treatment and vessel occlusion.
A system for treating an aneurysm include an expandable barrier positionable to bridge an aneurysm neck. Obstacles could include a fiber mesh, a balloon or a Molly anchor member, and may not open, reveal, or inflate from a compact configuration to an expanded configuration. Expanding the obstacles become larger radially than axially. A vaso-occlusive member comprising a coil or wells can be placed in the aneurysm. Another aneurysm treatment system comprising an outer Fenestrated stent and / or an inner Fenestrated arm, to be put together next to an aneurysm neck to control blood flow into the aneurysm. arm may be movable relative to the stent to open or occlude the fenestrations, which may vary in size, shape, and distribution. An intra-luminal vessel occlusion device consists of a stent and a sheath. A drawstring can be operated slowly destroying a sheath orifice to control the blood vessels.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Radiation imaging method with individual signal resolution

Protect your invention by filing a Provisional or Utility Patent Application using our software today! It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Southern Innovation International Pty Ltd. patent solves the following problem:

Molecular Imaging is emerging as a powerful and sensitive method for functional imaging of biological functions in the human body. In particular Single Photon out computed tomography (respect) and positron emission tomography (PET), two of the most effective technologies for the detection and staging of cancer.

Our analysis of this patent is as follows:

Southern Innovation International Pty Ltd.’s patent US 8471210 B2 deals with Radiation imaging method with individual signal resolution.
An imaging method and apparatus are provided. method includes collecting detector output data from a radiation detector positioned near a subject given to a radio-active tracer method further includes addressing individual data signal to the detector output by determining the a signal to signal in the data, and make predictions basis of one or more parameters of signal. The one or more parameters including at least a signal temporal position. method further includes determining the strength of each of the signal from at least the signal form and the parameter estimates.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Energetic modulation of nerves

File for Quick & Easy Patent Protection with PowerPatent.

The Kona Medical, Inc. patent solves the following problem:

Energy delivery from a distance includes the transmission of energy waves affect a target at a distance. This allows for more efficient delivery of energy to target and with a greater cost efficiency and technologic flexibility in generating side. For example, cellular phones will target the tower near the user and the towers to communicate with one another over a long range; this way, the cell phone will be lower powered and communicate over a relatively small range on the network can communicate easily around the world. Similarly, electricity distribution from generation station users is better than the users themselves to look for solutions.

Our analysis of this patent is as follows:

Kona Medical, Inc.’s patent US 8469904 B2 deals with Energetic modulation of nerves.
A method of using a root inhibiting cloud around a blood vessel includes creating a treatment plan, which implements the treatment plan using the root inhibiting cloud to at least a majority part of a circumference of a blood vessel wall, and applying the root inhibiting cloud to the majority of the circumference of the blood vessel wall for a time sufficient to inhibit the function of an artery around the vessel the blood wall.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Rapid paging based on device mobility and coverage area mobility

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The Sprint Spectrum L.P. patent solves the following problem:

In a typical cellular wireless communication system, a place geographically divided into a number of cells and cell sectors, each defined by a radio frequency (RF) radiation pattern from an individual the base station antenna. The base station antenna in the cells could be combined with a base station controller, which will be accompanied by a switch or gateway that provides connectivity of a transport network such as public switched telephone network (PSTN) or the Internet.

Our analysis of this patent is as follows:

Sprint Spectrum L.P.’s patent US 8472982 B1 deals with Rapid paging based on device mobility and coverage area mobility.
Said here are the ideal methods and systems that help determine when to make a strong temptation page somewhere coverage, by using the Zone-based paging. An exemplary method includes: (a) in a radio access network, determining that a wireless communication device (WCD) had liked the book; (B) responsive to determining that the WCD had paged through: (i) to determine a final-known coverage area of ​​WCD, (ii) based at least in part to a WCD action signs WCD and a coverage area that act marked the end of the known coverage area, determine a general indication that action, and (iii) the use of general activities sign as a basis for determining whether or not to make a strong temptation pages of WCD; (C) If it is determined to make a strong temptation, then do the rapid test page to the last-known sector; and (d) if not, use a zone-based paging procedure on page WCD.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Method and system of fabricating alternating phase shift mask

Protect your invention by filing a Provisional or Utility Patent Application using our software today! It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The SK Hynix Inc. patent solves the following problem:

Exemplary embodiments of the present invention relates to a photomask for use in a semiconductor fabrication, and more particularly, to a method and system for fabricating an alternating phase shift mask.

Our analysis of this patent is as follows:

SK Hynix Inc.’s patent US 8470499 B2 deals with Method and system of fabricating alternating phase shift mask.
An alternating phase shift mask fabricated by defining transparent region by building light blocking pattern on a transparent substrate and forming an etch stop layer in the transparent substrate in a phase shift between regions transparent regions. The transparent substrate of transition region can be etched and the etching can be considered completed based on the radiation detected in an area under the etch stop layer.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Pyrimidinecarboxamide derivatives as inhibitors of Syk kinase

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The Glaxo Group Limited patent solves the following problem:

Our analysis of this patent is as follows:

Glaxo Group Limited’s patent US 8470835 B2 deals with Pyrimidinecarboxamide derivatives as inhibitors of Syk kinase.
The present invention relates to a compound of formula (I): or a salt, preferably a pharmaceutically acceptable salt thereof; is an inhibitor of spleen tyrosine kinase (SYK) and therefore potential use in the treatment of diseases that result in inappropriate activation of mast cell, for example, allergic and inflammatory diseases, as well as the potential use of cancer therapy, especially heme malignancies.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Compositions, methods, and kits for amplifying nucleic acids

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The Applied Biosystems, Llc patent solves the following problem:

Our analysis of this patent is as follows:

Applied Biosystems, Llc’s patent US 8470531 B2 deals with Compositions, methods, and kits for amplifying nucleic acids.
The present teachings are directed to compositions, methods, and kits for amplifying target nucleic acid while reducing non-specific fluorescence and undesired amplification products, sometimes called secondary amplification products or mini side -the product. The enzyme inhibitor expressed here comprising a nucleotide sequence and at least a quench. Complexes containing an enzyme inhibitor associated with an enzyme, wherein at least one enzymatic activity of the enzyme that inhibits, given also. Methods for raising a target nucleic acid while reducing undesirable products profit expressed as methods for reducing non-specific fluorescence. Kits to facilitate the performance of certain disclosed methods is also given.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Solid forms of an anti-HIV phosphoindole compound

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The Idenix Pharmaceuticals, Inc. patent solves the following problem:

Indoles, nucleosides and their analogues used in the treatment of viral infections in mammals, including humans. Viruses that infect mammals and treated by the administration of pharmaceutical compositions that contain indoles, nucleosides or their analogues or derivatives include hepatitis C virus (HCV), human immunodeficiency virus (HIV), pestiviruses and flaviviruses (Moennig et al ., adv. Vir. Res 1992, 41 :. 53-98; Meyers and Thiel, adv viral Res 1996, 47: 53-118; Moennig et al, adv Vir Res 1992, 41: …… 53 -98; Halstead. Pin infect Dis 1984, 6: 251-64; Halstead, Science 1988, 239 :. 476-81; Monath, New Engl J Med 1988, 319: 641-3) …

Our analysis of this patent is as follows:

Idenix Pharmaceuticals, Inc.’s patent US 8470870 B2 deals with Solid forms of an anti-HIV phosphoindole compound.
Solid forms contain a compound that is useful in the treatment, prevention and control of various conditions and diseases given here. In particular, given here are the strongest forms comprising (2-carbamoyl-5-chloro-1H-indol-3-YL) – [3 – ((E) -2-cyano-vinyl) – 5-methyl-phenyl] – (R) -phosphinic acid methyl ester, including its salts, which have utility for the treatment, prevention and control of conditions and disorders including, but not limited to, human immunodeficiency virus infection .

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.